ISOLATED ANTIBODY THAT BINDS A VASCULAR ENDOTHELIAL CELL GROWTH FACTOR-E (VEGF-E) POLYPEPTIDE AND USE THEREOF FOR THE PREPARATION OF AND AS MEDICAMENTS FOR INHIBITING OR PREVENTING GROWTH OF CANCER CELLS OR ANGIOGENESIS, METHOD USING IT AND AN ARTICLE OF MANUFACTURE CONTAINING IT
The present invention involves the identification and preparation of vascular endothelial growth factor-E (VEGF-E). VEGF-E is a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1. VEGF-E has homology to VEGF including conservation of the amino acids required for activity of VEGF. VEGF-E can be useful in wound repair, as well as in the generation and regeneration of tissue.
